Point-of-care biomarker assay for traumatic brain injury

Intracranial abnormalities on CT scan in patients with traumatic brain injury (TBI) can be predicted by glial fibrillary acidic protein (GFAP) levels in the blood. These interim findings from the TRACK-TBI study are published in the peer-reviewed Journal of Neurotrauma. GFAP’s diagnostic performance was significantly better than that of the S100B biomarker, to which it was compared. S100B is approved […]

Read more